Ponoi Ii Management is an investment fund managing more than $38.3 million ran by James Evangelista. There are currently 4 companies in Mr. Evangelista’s portfolio. The largest investments include Ngm Biopharmaceuticals Inc and Revolution Medicines Inc, together worth $30.5 million.
As of 7th November 2022, Ponoi Ii Management’s top holding is 1,298,908 shares of Ngm Biopharmaceuticals Inc currently worth over $17 million and making up 44.4% of the portfolio value.
Relative to the number of outstanding shares of Ngm Biopharmaceuticals Inc, Ponoi Ii Management owns more than approximately 0.1% of the company.
In addition, the fund holds 685,011 shares of Revolution Medicines Inc worth $13.5 million, whose value fell approximately 0.1% in the past six months.
The third-largest holding is Nurix Therapeutics worth $4.26 million and the next is RAPT Therapeutics worth $3.5 million, with 145,401 shares owned.
Currently, Ponoi Ii Management's portfolio is worth at least $38.3 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Ponoi Ii Management office and employees reside in San Francisco, California. According to the last 13-F report filed with the SEC, James Evangelista serves as the Chief Financial Officer at Ponoi Ii Management.
The two most similar investment funds to Ponoi Ii Management are Autonomy Capital (jersey) L.P. and Arrow Capital Management. They manage $38.3 million and $38.3 million respectively.
Ponoi Ii Management’s portfolio is diversified across 1 sector.
Currently, their heaviest sector is Health Care — making up 100.0% of
the total portfolio value.
The fund focuses on investments in the United States as
100.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $962 million.
These positions were updated on November 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Ngm Biopharmaceuticals Inc |
No change
1,298,908
|
$16,990,000 | 44.41% |
| Revolution Medicines Inc |
No change
685,011
|
$13,508,000 | 35.31% |
| Nurix Therapeutics, Inc. |
No change
327,123
|
$4,262,000 | 11.14% |
| RAPT Therapeutics, Inc. |
No change
145,401
|
$3,498,000 | 9.14% |
| No transactions found | |||
| Showing first 500 out of 4 holdings | |||